Objective-Hemorrhagic transformation is a serious complication of ischemic stroke after recanalization therapies. This study aims to identify mechanisms underlying hemorrhagic transformation after cerebral ischemia/reperfusion. Approach and Results-We used wild-type mice and Selplg −/− and Fut7 −/− mice defective in P-selectin binding and lymphopenic Rag2 −/− mice. We induced 30-minute or 45-minute ischemia by intraluminal occlusion of the middle cerebral artery and assessed hemorrhagic transformation at 48 hours with a hemorrhage grading score, histological means, brain hemoglobin content, or magnetic resonance imaging. We depleted platelets and adoptively transferred T cells of the different genotypes to lymphopenic mice. Interactions of T cells with platelets in blood were studied by flow cytometry and image stream technology. We show that platelet depletion increased the bleeding risk only after large infarcts. Lymphopenia predisposed to hemorrhagic transformation after severe stroke, and adoptive transfer of T cells prevented hemorrhagic transformation in lymphopenic mice. CD4 + memory T cells were the subset of T cells binding P-selectin and platelets through functional P-selectin glycoprotein ligand-1. Mice defective in P-selectin binding had a higher hemorrhagic score than wild-type mice. Adoptive transfer of T cells defective in P-selectin binding into lymphopenic mice did not prevent hemorrhagic transformation. Conclusions-The study identifies lymphopenia as a previously unrecognized risk factor for secondary hemorrhagic transformation in mice after severe ischemic stroke. T cells prevent hemorrhagic transformation by their capacity to bind platelets through P-selectin. The results highlight the role of T cells in bridging immunity and hemostasis in ischemic stroke. Visual Overview-An online visual overview is available for this article.
R emarkable progress has been made in recent years in the treatment of acute ischemic stroke with the wider implementation of systemic and endovascular reperfusion therapies. 1 However, some patients may remain functionally dependent or die despite these interventions as the result of complications. Hemorrhagic transformation (HT), or bleeding into an area of ischemic brain, ranges from small petechiae to large parenchymatal hematomas. 2 HT occurs in ≈12% of patients with ischemic stroke, 3 but the risk increases to 26% after revascularization therapies. 4 HT is considered clinically relevant when it becomes symptomatic (symptomatic intracerebral hemorrhage [sICH] ), which occurs in ≈3% of patients receiving systemic thrombolysis 5 and 5% of patients treated with combined intravenous and intra-arterial therapy. 4 The overall rate of sICH after mechanical thrombectomy is 4.4%, 6 but it may increase up to 11.3% when multiple device passes are required to achieve recanalization. 7 Several clinical features, blood markers, genetic factors, and neuroimaging findings have been associated with HT in patients with ischemic stroke. 8, 9 HT is more frequent after large infarctions, 3, 5, [8] [9] [10] and critical determinants are severe damage of the vascular endothelium and the blood-brain barrier. 8, 11, 12 Yet, better understanding of the mechanisms underlying HT is of utmost clinical relevance because it may lead to identifying more sensitive predictors and new therapeutic strategies to minimize the burden of this serious complication.
Recent studies suggested that the neutrophil to lymphocyte ratio (NLR) predicted an increased risk of sICH after thrombolytic therapy in patients with stroke. 13 However, it is currently unknown whether there is a causal association between neutrophils, NLR, and the hemorrhagic risk or, alternatively, whether changes in white blood cells follow the severity of stroke, or concurrent complications. Acute stroke induces lymphopenia by mechanisms involving complex neurohormonal responses. [14] [15] [16] [17] However, there is no information on whether stroke-induced lymphopenia increases the hemorrhagic risk.
Leukocytes interact with platelets 18 though several mechanisms, such as platelet P-selectin binding to PSGL-1 (P-selectin glycoprotein ligand-1 or CD162), which is expressed in neutrophils and T cells, but not B cells. [19] [20] [21] Functional P-selectin binding epitopes in the PSGL-1 molecule require post-translational modifications involving protein glycosylation mediated by various glycosyltransferases, including Fut7 (fucosyltransferase 7). 22 Expression of Fut7 in T lymphocytes is inducible on activation and polarization of naive T cells, and it is required for T-cell migration into inflamed tissues. [22] [23] [24] T cells exacerbate brain damage after cerebral ischemia/reperfusion because they facilitate platelet and leukocyte adhesion to the vessel wall and promote thromboinflammation. 25, 26 In our study, postischemic lymphopenia facilitated HT. We used Rag2 −/− mice, which show severe lymphopenia because of lack of αβ and γδ T cells, B cells, and NKT (natural killer T cells) cells. These mice were prone to HT after severe ischemic stroke unless they were reconstituted with T cells. This study identified a new mechanism mediated by the PSGL-1/Pselectin axis by which T cells and platelets prevent secondary HT after severe brain ischemia/reperfusion in mice.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. An extended version of this section is available in the online-only Data Supplement.
Animals
We used adult (10-16 weeks) male mice on the C57BL/6J background (n=584 
Brain Ischemia
Occlusion of the right middle cerebral artery (MCAo) was performed under isoflurane anesthesia using a monofilament (no. 701912PK5Re, Doccol Corporation, Sharon, MA), as described. 29 Two days postischemia, we assessed the neurological dysfunction with a neurological score modified from a previously reported neuroscore.
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Drug Treatments
Treatment was randomly allocated and was administered in a blinded fashion. Ten minutes after reperfusion, mice received an intraperitoneal injection of rabbit anti-mouse platelet serum (15 μL diluted in saline to 200 μL; no. CLA31440, Cederlane) or the vehicle (saline).
Evaluation of HT
At 48 hours of reperfusion, mice were anesthetized with isoflurane and perfused through the heart with heparinized saline. The severity of brain hemorrhage was assessed in coronal brain sections (1-mm thick) of fresh tissue by giving scores (0-5, where 0 means absence of hemorrhage and 5 means large hematomas) 31 and with histological measures.
Magnetic Resonance Imaging
The mouse brain was studied with magnetic resonance imaging (7T, BioSpec, Bruker) using ParaVision 6.0 software. Infarct volume was measured on images obtained with T2*-weighted turboRARE fast spin-echo. 29 Cerebral blood flow was measured with a pulsed arterial spin labeling method. For assessment of brain bleeds, mice received a T2*-weighted magnetic resonance imaging scan using a gradientecho pulse sequence.
Immunofluorescence
Mice were perfused through the heart with heparinized saline followed by 4% paraformaldehyde, and the brain was processed to obtain cryostat sections for immunofluorescence. Primary antibodies were rabbit polyclonal antibodies against pan-laminin or Glut-1 (facilitated glucose transporter, member 1) and rat monoclonal antibodies against CD41. Please see the Major Resources Table in the online-only Data Supplement. Images were obtained on a confocal microscope (TCS SPE-II, Leica Microsystems) with LAS software (Leica). 
Isolation and Administration of T Cells for Adoptive Transfer
Quantification of Brain Hemoglobin Content
Brain hemoglobin content was determined with a colorimetric assay (no. 700540, Cayman Chemicals).
Blood Cell Counts
Blood was collected from the vena cava in EDTA and was analyzed in a hematology system (ADVIA2120i, Siemens).
Flow Cytometry
Cell isolation from brain tissue was performed as described. 32 Cells were incubated at 4°C for 10 minutes with FcBlock followed by primary antibodies. See the Major Resources Table in the online-only Data Supplement. Aqua (live/death, Molecular Probes) was used to gate on live cells. Brain cells and blood were studied in a BD FacsLSRII cytometer using the FacsDiva software (BD Biosciences). Data analysis was performed with FlowJo software (v10 FlowJo, LLC). P-selectin binding assay was performed using chimeric P-selectin/hIgM (human immunoglobulin M). Dynamic interactions of T cells with platelets were studied in diluted fresh whole blood, and cell conjugates were visualized with ImageStream MARKII technology (Amnis, EMD Millipore).
Platelet and T-Cell Conjugate Analysis
Diluted whole blood was prepared as described. 33 Briefly, 50 µL of blood was diluted in 200 µL of Tris-buffered saline containing 20 U/mL 
Statistics
The statistical tests used in each experiment and n values are reported in the Figure legends.
Results
Platelet Depletion Increases the Hemorrhagic Risk Only in Large Infarcts
Reperfusion therapies are not recommended in ischemic stroke patients with low platelet counts because of a high risk of HT. 34 Antiplatelet drugs also increase the risk of HT after reperfusion therapies, particularly in patients with large infarctions. 9 To find out the contribution of platelets in preventing hemorrhage secondary to brain ischemia, we treated mice with an antiplatelet serum that markedly reduced platelet numbers ( Figure 1A ). We induced different degrees of ischemic brain damage by MCAo for either 30 or 45 minutes. Forty-five-minute MCAo induced larger infarct volumes, as expected, and caused HT in some mice while HT was infrequent after 30-minute MCAo ( Figure I in the online-only Data Supplement). Platelet depletion after induction of ischemia ( Figure 1B ) did not significantly increase brain bleeding after 30-minute MCAo while it produced large hematomas after 45-minute MCAo ( Figure 1C and 1D). After 45-minute ischemia, we detected the presence of platelets in the ischemic brain tissue in different locations ( Figure 1E ), that is, intravascular platelets blocking the lumen of some capillaries, platelets within parenchymal hemorrhages, or platelet clusters surrounding the abluminal side of the endothelium. Platelets surrounded blood vessels in zones with extravasated fibrin(ogen; Figure 1E ), suggesting the formation of extravascular hemostatic clots sealing the ruptured vessels.
Involvement of NLR, Neutrophils, and Lymphocytes in HT
A high NLR is associated with HT in patients with ischemic stroke treated with thrombolysis. 13 We measured blood cell counts 48 hours after 45-minute ischemia to assess for the contribution of blood cells in HT in our stroke mouse models. Neutrophils tended to increase after ischemia, whereas lymphocyte numbers markedly decreased, in agreement with the reported stroke-induced lymphopenia, [14] [15] [16] [17] and the NLR as well as platelet numbers increased ( Figure 2A ). Infarct size was positively correlated to the hemorrhagic score ( Figure 2B ). Accordingly, examining infarct size in each category of HT score ( Figure 2C ) showed that mice with hemorrhages had larger infarctions and worse neurological deficits than mice devoid of bleeding (HT score=0) or with a few small petechiae (HT score=1; Figure 2D and 2E). Nonetheless, the mice with the highest hemorrhagic scores did not show the largest infarctions ( Figure 2D ), suggesting that the magnitude of bleeding might be influenced by other factors in addition to infarct size. We then examined blood cell counts in relation to the degree of hemorrhage. We did not find apparent relationships between the degree of hemorrhage and neutrophil numbers or the NLR ( Figure 2F and 2G) . However, the most noticeable finding was that mice with the highest hemorrhagic scores showed lower lymphocyte counts ( Figure 2H ), and lymphocyte counts were inversely correlated with the HT score ( Figure 2I ). To account for infarct size and lymphocyte counts, we calculated the volume-to-lymphocyte ratio by dividing infarct size (% of hemispheric volume) by blood lymphocyte number (cells/nL). The volume-to-lymphocyte ratio progressively increased with increasing hemorrhagic score ( Figure 2J ). These results suggest that the highest risk of bleeding occurs in large infarcts with the lowest lymphocyte counts.
Low T-Cell Numbers Increase HT After Severe Ischemia
Lymphopenic Rag −/− mice offer an experimental model to investigate whether low lymphocyte counts might be involved in HT. However, evidence shows that Rag −/− mice develop smaller lesions than the wild-type mice after transient ischemia, 25, 26 stressing that it is necessary to account for the extent of the infarct to address the relationship between lymphocytes and the risk of HT. Rag2 −/− mice showed smaller infarct volumes than the wild-type mice after 30-minute ischemia ( Figure II in the online-only Data Supplement). However, infarct volumes were similar in wild-type mice and Rag2 −/− mice after 45-minute ischemia, and we did not detect differences in cerebral blood flow recovery after MCAo between genotypes (Figure II in the online-only Data Supplement). Nonetheless, after 45-minute ischemia, the Rag2 −/− mice seemed to bleed more, as assessed macroscopically in the tissue sections ( Figure 3A ) and microscopically in paraffin sections ( Figure 3B ). To find out whether this effect was attributable to the lack of T cells, we performed adoptive transfer of T cells to Rag2 Figure 3C ; Figure IV in the online-only Data Supplement). We also quantified the brain hemoglobin content and performed T2*-weighted magnetic resonance imaging ( Figure 3D and 3E) . In all these measurements, adoptive transfer of T cells to the Rag2 −/− mice consistently reduced the signs of secondary hemorrhage. In independent groups of mice, we tested whether administration of T cells to Rag2 −/− mice affected the size of the brain lesion and the neurological deficit. T cells increased infarct volume after 30-minute MCAo but not after 45-minute MCAo (Figure 4) . However, in the latter severe ischemia model, adoptive transfer of T cells reduced the hemorrhagic score and attenuated the neurological deficits (Figure 4) . Altogether, these results showed that T cells prevented HT after ischemic stroke in mice with marked lymphopenia.
Crosstalk of T Cells and Platelets
Platelets support interaction of platelet-binding T cells to the vessel wall, 18 and T cells facilitate adhesion of leukocytes and platelets to the vascular endothelium after cerebral ischemia/ reperfusion. 25 We found fewer platelet clusters around blood vessels of the ischemic tissue of Rag2 −/− mice compared with wild-type mice but not after adoptive transfer of T cells ( Figure 5A ). The effect was not because of low platelet counts in these mice (mean±SD platelet number×10 3 , wild-type mice: 1240±205, n=8; Rag2 −/− mice: 1430±296, n=7). We detected T cells within zones of platelet accumulations in the infarcted brain tissue of wild-type mice ( Figure 5B ) and hypothesized that an interaction of T cells with platelets might be involved in preventing HT after ischemic stroke. Specific subsets of T cells form conjugates with platelets in blood. Results of blood counts for control mice (n=12) and ischemic mice 48 h after 45-min middle cerebral artery occlusion (MCAo; n=26). A, After ischemia, neutrophils tended to increase (unpaired t test with Welch correction, P=0.053), lymphocyte numbers strongly decreased (***P<0.001), the neutrophil to lymphocyte ratio (NLR) increased (***P<0.001), and platelet numbers increased (**P=0.006; Mann-Whitney tests). B, The hemorrhagic score was positively correlated with infarct volume (Spearman r=0.541; P=0.004; n=26). C, We grouped ischemic mice (n=26) according to their hemorrhagic score, as illustrated with representative brain tissue sections. There were n=6 mice in each score category, excepting for score=4 with n=2 mice. D, Infarct volume was larger for mice showing bleeds (Kruskal-Wallis test P=0.017; Dunn test **P<0.01 vs score=0). E, Similar results were found for the neurological score (Kruskal-Wallis test P=0.078; Dunn test **P<0.01 vs score=0). F and G, Neutrophils and the NLR showed no apparent changes between hemorrhagic score categories (Kruskal-Wallis test P=0.238), but mice with hemorrhagic score=4 had low neutrophils (Dunn test, P<0.05 vs score=0). H, Lymphocytes tended to decrease progressively for higher hemorrhagic scores (Kruskal-Wallis test P=0.080; Dunn text *P<0.05 vs score=0). I, The hemorrhagic score was inversely correlated with lymphocyte number (Spearman r=−0.554; P=0.003; n=26). J, To account for infarct size and lymphocyte number, we calculated for each mouse the volume-to-lymphocyte ratio (VLR) as the ratio between infarct volume and the number of blood lymphocytes (cell counts/nL). ) memory T cells unable to bind P-selectin showed less platelet-T cell conjugates than the wild-type T cells ( Figure 5D ).
Active P-Selectin Binding Sites in T Cells Are Required to Prevent HT After Severe Ischemic Stroke
In vivo, PSGL-1-deficient mice (Selplg −/− mice) showed a higher hemorrhagic score than wild-type mice after 45-minute ischemia ( Figure 6A ), suggesting that P-selectin binding was necessary to protect large infarcts from HT. To find out whether active P-selectin binding sites in T cells were involved in this effect, Rag2 HT after severe ischemia, in contrast to the effect of wildtype T cells ( Figure 6B ; Figure VII in the online-only Data Supplement). These results demonstrate that P-selectin binding through functional PSGL-1 confers T cells the property to prevent HT after severe ischemia. Given that the subset of T cells with P-selectin-binding capacity are the memory T cells, our result suggests that memory T cells induce prohemostatic effects in large cerebral infarctions at risk of bleeding.
Discussion
The current best treatment for ischemic stroke is reperfusion therapy with thrombolysis or mechanical thrombectomy in suitable patients. However, the benefits of these therapies may be hindered by complications, such as HT. HT occurs more frequently in patients with large infarctions, 3, 5, 9 but little is known about the underlying mechanisms. This study demonstrates that T cells reduce the risk of HT. It also confirms the relevance of infarct size as a critical factor that increases the hemorrhagic risk. Altogether, these results highlight the crosstalk between T cells and platelets bridging immunity and hemostasis to prevent HT after acute ischemic stroke.
Growing evidence supports the fact that platelets may contribute to the endothelial barrier function by providing physical coverage to the damaged endothelium and thus prevent vascular leakage at sites of severe endothelial injury. [35] [36] [37] Hence, our results support that platelets sealed the damaged vessels and reduced the leakage of blood to the ischemic brain parenchyma. This phenomenon was in part mediated by lymphocytes, given that lymphopenia favored HT in large infarctions but did not influence this risk of HT after small infarctions. Functional binding sites on PSGL-1 in T cells were necessary to prevent HT after severe ischemia. PSGL-1 interacts with selectins and is involved in leukocyte adhesion to the activated endothelium and platelets. 38, 39 Lymphocytes and platelets interact through a complex crosstalk with functional consequences for both cell types. 18 Memory CD4 + T cells are the circulating T cells that form conjugates with platelets. Platelet conjugation selectively enhances the adhesion of memory T cells to the endothelium of inflamed venules. 39 This phenomenon might underlie the recognized role of T cells in promoting thromboinflammation and worsening brain damage after ischemia/ reperfusion. 25, 26 However, platelets also support P-selectinmediated adhesion of lymphocytes to the arterial wall when blood flow is disturbed 40 and after exposure of subendothelial matrix proteins that can occur at arterial sites of injury. 41 Our study suggests that memory T cells facilitate the formation of platelet plugs in the abluminal side of severely injured vessels. We found that the mechanism involves the PSGL-1/P-selectin axis, but identification of the precise molecular and cellular determinants of T cell-mediated platelet aggregation around the injured vessels will require more investigation.
The results highlight the intimate crosstalk between platelets and lymphocytes and their double role in hemostasis and inflammation, which in the context of cerebral ischemia can bear predominantly negative (thrombo-inflammatory) or positive (hemostatic) effects, likely depending on the vascular bed, the integrity of the vessels, and the risk of HT. T-cell prohemostatic effects prevail in large infarctions at risk of experiencing HT. In contrast, detrimental effects of T cells become apparent in infarctions of mild or moderate size bearing a low risk of HT. This study identifies lymphopenia as a risk factor for HT of large infarctions, raising the question of whether T-cell administration after severe stroke could potentially reduce HT without exacerbating brain damage. Interestingly, a recent study reported that administration of regulatory T cells reduced HT induced by delayed treatment with tissue-type plasminogen activator (tPA) in suture and embolic stroke mouse models, and the effect was related to attenuation of tPA-induced endothelial damage. 42 PSGL-1 is involved in the suppressive activity of regulatory T cells, at least under certain experimental conditions. 43 Further studies are needed to find out whether PSGL-1 mediates the effects of regulatory T cells in stroke.
Previous clinical studies have stressed the contribution of neutrophils and the NLR to the risk of HT after thrombolysis. 13, 44 In contrast, we did not find a clear relationship between neutrophil counts and the NLR with HT. A main difference between our study and those previous studies is that we did not use tPA. tPA promotes neutrophil transmigration to reperfused tissue via proteolytic activation of plasmin and gelatinases, 45 and it induces neutrophil degranulation. 46 Furthermore, neutrophil extracellular traps impair tPA-induced thrombolysis. 47 Therefore, the potentially damaging effect of neutrophils at the blood-brain barrier could be exaggerated by tPA.
Animals with large infarctions develop lymphopenia but the extent of the response shows some variation potentially attributable to the magnitude of neurohormonal responses. 17 Several lines of evidence suggest the possibility of neuroanatomical correlates of stroke-induced immunodepression 48 that could explain why poststroke lymphopenia is more severe in some individuals than others despite similarly large lesion sizes. A limitation of our study is that it was performed only in male mice. The results will require validation in female mice because of sex-dependent differences in the inflammatory response and contribution of immune cells to stroke outcome. 49 Collectively, our results highlight the role of platelets and memory T lymphocytes attenuating HT of ischemic stroke by binding platelets through functional PSGL-1, thus identifying a new cellular and molecular target for secondary HT prevention after ischemic stroke. 
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